Amphastar Pharma (AMPH) Ticks Lower Following Cautious Report

September 23, 2016 3:34 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Amphastar Pharma (NASDAQ: AMPH) ticked lower Friday following a cautious report at theStreet that suggested the cost of Naloxone could be the subject in the next drug price scandal.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Rumors, Trader Talk

Add Your Comment